Financhill
Back

Embecta Vs. Perspective Therapeutics Industry Stock Comparison

Buy
67

EMBC
Embecta

Last Price:
14.52
Seasonality Move:
1.2%
Sell
30

CATX
Perspective Therapeutics

Last Price:
12.11
Seasonality Move:
26.28%
Buy
67
Embecta (EMBC) is a Buy

Is Embecta a Buy, Sell or Hold?

  • The current Embecta [EMBC] share price is $14.54. The Score for EMBC is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • EMBC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $12.19. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EMBC Stock Price Chart

What is Embecta's stock price today?

  • The Embecta share price today is $14.54
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EMBC is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $12.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

EMBC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 56.58 Buy
Chaikin Money Flow: 96967 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.24 - 14.28) Buy
Bollinger Bands (100): (12.81 - 15.43) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.38 Sell
Relative Strength Index (14 RSI): 46.93 Sell
Chaikin Money Flow: -154562 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.92 - 13.12) Sell
Bollinger Bands (100): (11.23 - 14.35) Sell

EMBC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.22 Buy
20-day SMA: 13.76 Buy
50-day SMA: 14.6 Sell
200-day SMA: 13.77 Buy
8-day EMA: 14.22 Buy
20-day EMA: 14.09 Buy
50-day EMA: 14.21 Buy
200-day EMA: 14.75 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.85 Buy
20-day SMA: 12.37 Sell
50-day SMA: 13.45 Sell
200-day SMA: 12.59 Sell
8-day EMA: 12 Buy
20-day EMA: 12.31 Sell
50-day EMA: 12.84 Sell
200-day EMA: 11.76 Buy

Embecta Earnings Growth & EMBC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.41 per share, and a decrease next year of $0.12 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.17 per share.

Embecta Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):